Chongqing Pharscin Pharmaceutical Co Ltd (002907) — Capital Reinvestment Ratio
Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Capital Reinvestment Ratio of 5.05x as of September 2025, meaning it reinvests 5% of its operating cash flow (CN¥833.94K) in capital expenditures (CN¥4.21 Million). Check tangible equity quality of Chongqing Pharscin Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chongqing Pharscin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Chongqing Pharscin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Chongqing Pharscin Pharmaceutical Co Ltd.
Annual Capital Reinvestment Ratio for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Chongqing Pharscin Pharmaceutical Co Ltd from 2013 to 2024. See 002907 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥161.77 Million | CN¥16.15 Million | ▼ -76.4% |
| 2023 | 0.42x | CN¥219.34 Million | CN¥92.82 Million | ▼ -90.9% |
| 2022 | 4.65x | CN¥13.04 Million | CN¥60.62 Million | ▲ +579.7% |
| 2021 | 0.68x | CN¥82.85 Million | CN¥56.64 Million | ▲ +66.4% |
| 2020 | 0.41x | CN¥113.64 Million | CN¥46.69 Million | ▼ -58.1% |
| 2019 | 0.98x | CN¥65.92 Million | CN¥64.66 Million | ▼ -14.1% |
| 2018 | 1.14x | CN¥31.80 Million | CN¥36.30 Million | ▲ +121.8% |
| 2017 | 0.51x | CN¥81.34 Million | CN¥41.87 Million | ▲ +78.1% |
| 2016 | 0.29x | CN¥57.73 Million | CN¥16.69 Million | ▲ +18.0% |
| 2015 | 0.25x | CN¥66.10 Million | CN¥16.20 Million | ▼ -64.1% |
| 2014 | 0.68x | CN¥20.22 Million | CN¥13.79 Million | ▲ +69.3% |
| 2013 | 0.40x | CN¥47.34 Million | CN¥19.06 Million | — |